It’s pleasure to welcome Thomas in our team. After a four-month internship at the CrCHUM (Centre de recherche du Centre Hospitalier de l’Université de Montréal, Canada) in the field of microfluidic personalized medicine for prostate cancer, he joined us in September for a six- months-internship, as part of his Master’s degree in biotechnology (University of Lille), specializing in cellular and molecular engineering.
In the context of our LabCom called BioPharMEMS, he will develop a 3D in vitro breast cancer model of vascularized tumor in a microfluidic device using BIOMIMESYS® Oncology.
0 Comments